Study to Evaluate the Efficacy & Safety of DWP14012 in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT01452776` - Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis	Phase 3
Recruiting	`NCT05587309` - A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis	Phase 3
Completed	`NCT04124926` - Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis	Phase 3
Completed	`NCT01459367` - Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis	Phase 3
Completed	`NCT00228527` - Esomeprazole for Treatment of GERD in Pediatric Patients	Phase 4
Completed	`NCT01499368` - A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients	Phase 3
Not yet recruiting	`NCT04613895` - Treatment Effect According to Timing of Administration of DWP14012 40 mg	N/A
Recruiting	`NCT02615184` - A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children	Phase 2
Completed	`NCT02456935` - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis	Phase 3
Completed	`NCT02028663` - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis	Phase 2
Completed	`NCT03006874` - Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis	Phase 3
Completed	`NCT02388724` - Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis	Phase 3
Completed	`NCT01865825` - Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?	N/A
Completed	`NCT02679508` - Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety	Phase 4
Recruiting	`NCT06391177` - A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily	Phase 1
Completed	`NCT05050188` - A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008	Phase 1
Completed	`NCT01874535` - Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy	Phase 4
Completed	`NCT00206180` - NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis	Phase 4
Completed	`NCT01630746` - A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis	Phase 3
Completed	`NCT01642615` - Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents	Phase 2

NCT number	NCT03736369
Study type	Interventional
Source	Daewoong Pharmaceutical Co. LTD.
Contact
Status	Completed
Phase	Phase 3
Start date	December 13, 2018
Completion date	August 7, 2019

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms